Mr Christopher Ogden is one of the pioneering Urologists with regards to HIFU treatment which began at the same time as his pioneering work in robotic surgery.
He is one of the few surgeons in the world who has assessed the comparisons between whole gland HIFU and robotic surgery and more recently he co-authored a paper on the outcomes of whole gland HIFU which was accepted for publication in the Journal of Urology.
He is also one of the leading Consultants in the multicentre index trial. The index trial focuses on the clinical effectiveness of focal HIFU and promises to offer certain men better functional outcomes with regards to treatment for prostate cancer. It carefully assesses the early oncological outcomes which have been encouraging in small groups of patients with early follow up.